Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins.

PubWeight™: 3.31‹?› | Rank: Top 1%

🔗 View Article (PMC 4032847)

Published in Genome Res on April 02, 2014

Authors

Sojung Kim1, Daesik Kim1, Seung Woo Cho1, Jungeun Kim1, Jin-Soo Kim1

Author Affiliations

1: Department of Chemistry, Seoul National University, Seoul 151-747, South Korea; Center for Genome Engineering, Institute for Basic Science, Seoul 151-747, South Korea.

Articles citing this

(truncated to the top 100)

Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo. Nat Biotechnol (2014) 2.75

Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery. Elife (2014) 2.65

Multiplex CRISPR/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy. Nat Commun (2015) 2.56

Enhancing homology-directed genome editing by catalytically active and inactive CRISPR-Cas9 using asymmetric donor DNA. Nat Biotechnol (2016) 2.34

Small molecule-triggered Cas9 protein with improved genome-editing specificity. Nat Chem Biol (2015) 2.13

Correction of a pathogenic gene mutation in human embryos. Nature (2017) 2.09

Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA. Genome Res (2014) 1.91

A mouse geneticist's practical guide to CRISPR applications. Genetics (2014) 1.81

DNA-free genome editing in plants with preassembled CRISPR-Cas9 ribonucleoproteins. Nat Biotechnol (2015) 1.68

Cloning-free CRISPR/Cas system facilitates functional cassette knock-in in mice. Genome Biol (2015) 1.64

High-Throughput, High-Resolution Mapping of Protein Localization in Mammalian Brain by In Vivo Genome Editing. Cell (2016) 1.53

Generation of knock-in primary human T cells using Cas9 ribonucleoproteins. Proc Natl Acad Sci U S A (2015) 1.49

Genome-editing Technologies for Gene and Cell Therapy. Mol Ther (2016) 1.41

CRISPR/Cas9 editing of induced pluripotent stem cells for engineering inflammation-resistant tissues. Arthritis Rheumatol (2016) 1.39

Targeted Mutagenesis, Precise Gene Editing, and Site-Specific Gene Insertion in Maize Using Cas9 and Guide RNA. Plant Physiol (2015) 1.39

Applications of CRISPR technologies in research and beyond. Nat Biotechnol (2016) 1.34

Applications of the CRISPR-Cas9 system in cancer biology. Nat Rev Cancer (2015) 1.32

Photoactivatable CRISPR-Cas9 for optogenetic genome editing. Nat Biotechnol (2015) 1.28

Target specificity of the CRISPR-Cas9 system. Quant Biol (2014) 1.23

Off-target Effects in CRISPR/Cas9-mediated Genome Engineering. Mol Ther Nucleic Acids (2015) 1.23

Adenovirus-Mediated Somatic Genome Editing of Pten by CRISPR/Cas9 in Mouse Liver in Spite of Cas9-Specific Immune Responses. Hum Gene Ther (2015) 1.18

Targeted genome editing in primate embryos. Cell Res (2015) 1.10

CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes. Cell (2016) 1.08

Evaluation of TCR Gene Editing Achieved by TALENs, CRISPR/Cas9, and megaTAL Nucleases. Mol Ther (2015) 1.04

Efficient and transgene-free genome editing in wheat through transient expression of CRISPR/Cas9 DNA or RNA. Nat Commun (2016) 1.04

Defining and improving the genome-wide specificities of CRISPR-Cas9 nucleases. Nat Rev Genet (2016) 1.03

Genome-wide target specificities of CRISPR-Cas9 nucleases revealed by multiplex Digenome-seq. Genome Res (2016) 1.01

Synthetic epigenetics-towards intelligent control of epigenetic states and cell identity. Clin Epigenetics (2015) 0.99

Measuring and Reducing Off-Target Activities of Programmable Nucleases Including CRISPR-Cas9. Mol Cells (2015) 0.97

Creating and evaluating accurate CRISPR-Cas9 scalpels for genomic surgery. Nat Methods (2015) 0.96

CRISPR/Cas9-induced knockout and knock-in mutations in Chlamydomonas reinhardtii. Sci Rep (2016) 0.94

CRISPR-Cas: biology, mechanisms and relevance. Philos Trans R Soc Lond B Biol Sci (2016) 0.93

Large genomic fragment deletion and functional gene cassette knock-in via Cas9 protein mediated genome editing in one-cell rodent embryos. Sci Rep (2015) 0.93

Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform. Biochim Biophys Acta (2015) 0.92

Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9. Cell Rep (2016) 0.91

Methods for Optimizing CRISPR-Cas9 Genome Editing Specificity. Mol Cell (2016) 0.91

Genome editing in maize directed by CRISPR-Cas9 ribonucleoprotein complexes. Nat Commun (2016) 0.90

Enabling functional genomics with genome engineering. Genome Res (2015) 0.90

A scalable strategy for high-throughput GFP tagging of endogenous human proteins. Proc Natl Acad Sci U S A (2016) 0.90

DNA-free two-gene knockout in Chlamydomonas reinhardtii via CRISPR-Cas9 ribonucleoproteins. Sci Rep (2016) 0.90

Precision cancer mouse models through genome editing with CRISPR-Cas9. Genome Med (2015) 0.89

Efficient DNA-free genome editing of bread wheat using CRISPR/Cas9 ribonucleoprotein complexes. Nat Commun (2017) 0.89

RNA-guided genome editing in Drosophila with the purified Cas9 protein. G3 (Bethesda) (2014) 0.88

Structure and Engineering of Francisella novicida Cas9. Cell (2016) 0.88

DNA-binding-domain fusions enhance the targeting range and precision of Cas9. Nat Methods (2015) 0.88

Genome Editing in Human Pluripotent Stem Cells: Approaches, Pitfalls, and Solutions. Cell Stem Cell (2016) 0.87

CRISPR-Cas9 delivery to hard-to-transfect cells via membrane deformation. Sci Adv (2015) 0.86

CRISPRs for Optimal Targeting: Delivery of CRISPR Components as DNA, RNA, and Protein into Cultured Cells and Single-Cell Embryos. Hum Gene Ther (2016) 0.85

Genome-editing technologies for gene correction of hemophilia. Hum Genet (2016) 0.85

Promoting Cas9 degradation reduces mosaic mutations in non-human primate embryos. Sci Rep (2017) 0.85

Streptococcus thermophilus CRISPR-Cas9 Systems Enable Specific Editing of the Human Genome. Mol Ther (2015) 0.84

CRISPR/Cas9-induced disruption of gene expression in mouse embryonic brain and single neural stem cells in vivo. EMBO Rep (2016) 0.83

Kinetics of the CRISPR-Cas9 effector complex assembly and the role of 3'-terminal segment of guide RNA. Nucleic Acids Res (2016) 0.83

TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy. J Clin Invest (2014) 0.83

Origins of Programmable Nucleases for Genome Engineering. J Mol Biol (2015) 0.83

Site-directed mutagenesis in Petunia × hybrida protoplast system using direct delivery of purified recombinant Cas9 ribonucleoproteins. Plant Cell Rep (2016) 0.83

A new age in functional genomics using CRISPR/Cas9 in arrayed library screening. Front Genet (2015) 0.83

Targeted gene editing by transfection of in vitro reconstituted Streptococcus thermophilus Cas9 nuclease complex. RNA Biol (2015) 0.82

Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles. Proc Natl Acad Sci U S A (2016) 0.81

Genome editing comes of age. Nat Protoc (2016) 0.81

Different Effects of sgRNA Length on CRISPR-mediated Gene Knockout Efficiency. Sci Rep (2016) 0.81

DNA-free genome editing methods for targeted crop improvement. Plant Cell Rep (2016) 0.80

Improved cell-penetrating zinc-finger nuclease proteins for precision genome engineering. Mol Ther Nucleic Acids (2015) 0.80

Multidimensional chemical control of CRISPR-Cas9. Nat Chem Biol (2016) 0.80

Small molecules targeting microRNA for cancer therapy: Promises and obstacles. J Control Release (2015) 0.80

CRISPR/Cas9-mediated gene editing in human zygotes using Cas9 protein. Mol Genet Genomics (2017) 0.79

From Loci to Biology: Functional Genomics of Genome-Wide Association for Coronary Disease. Circ Res (2016) 0.79

High-Content Analysis of CRISPR-Cas9 Gene-Edited Human Embryonic Stem Cells. Stem Cell Reports (2016) 0.79

CRISPR/Cas9-mediated gene manipulation to create single-amino-acid-substituted and floxed mice with a cloning-free method. Sci Rep (2017) 0.79

CRISPR/Cas9: Implications for Modeling and Therapy of Neurodegenerative Diseases. Front Mol Neurosci (2016) 0.79

Non-homologous DNA increases gene disruption efficiency by altering DNA repair outcomes. Nat Commun (2016) 0.78

The Rise of CRISPR/Cas for Genome Editing in Stem Cells. Stem Cells Int (2016) 0.78

The history and market impact of CRISPR RNA-guided nucleases. Curr Opin Virol (2015) 0.78

CRISPR-Cas9(D10A) nickase-based genotypic and phenotypic screening to enhance genome editing. Sci Rep (2016) 0.78

Salient Features of Endonuclease Platforms for Therapeutic Genome Editing. Mol Ther (2016) 0.78

Controlled delivery of β-globin-targeting TALENs and CRISPR/Cas9 into mammalian cells for genome editing using microinjection. Sci Rep (2015) 0.78

Genome surgery using Cas9 ribonucleoproteins for the treatment of age-related macular degeneration. Genome Res (2017) 0.78

Genome Editing and Its Applications in Model Organisms. Genomics Proteomics Bioinformatics (2016) 0.77

Oscillating high-aspect-ratio monolithic silicon nanoneedle array enables efficient delivery of functional bio-macromolecules into living cells. Sci Rep (2015) 0.77

Germ line genome editing in clinics: the approaches, objectives and global society. Brief Funct Genomics (2015) 0.77

TRIM33 switches off Ifnb1 gene transcription during the late phase of macrophage activation. Nat Commun (2015) 0.77

Non-viral delivery of genome-editing nucleases for gene therapy. Gene Ther (2016) 0.77

The expanding footprint of CRISPR/Cas9 in the plant sciences. Plant Cell Rep (2016) 0.77

A Cas9 Ribonucleoprotein Platform for Functional Genetic Studies of HIV-Host Interactions in Primary Human T Cells. Cell Rep (2016) 0.77

Single-Cell-State Culture of Human Pluripotent Stem Cells Increases Transfection Efficiency. Biores Open Access (2016) 0.77

Minimizing off-Target Mutagenesis Risks Caused by Programmable Nucleases. Int J Mol Sci (2015) 0.77

BATCH-GE: Batch analysis of Next-Generation Sequencing data for genome editing assessment. Sci Rep (2016) 0.77

Mapping the genomic landscape of CRISPR-Cas9 cleavage. Nat Methods (2017) 0.76

Rapid Evolution of Manifold CRISPR Systems for Plant Genome Editing. Front Plant Sci (2016) 0.76

Carbonic anhydrase enzymes regulate mast cell-mediated inflammation. J Exp Med (2016) 0.76

Improved delivery of Cas9 protein/gRNA complexes using lipofectamine CRISPRMAX. Biotechnol Lett (2016) 0.76

Enhanced gene targeting to evaluate Lynch syndrome alterations. Proc Natl Acad Sci U S A (2016) 0.76

Knocking out consumer concerns and regulator's rules: efficient use of CRISPR/Cas ribonucleoprotein complexes for genome editing in cereals. Genome Biol (2017) 0.76

Recent Advances in Genome Editing Using CRISPR/Cas9. Front Plant Sci (2016) 0.76

Systematic gene tagging using CRISPR/Cas9 in human stem cells to illuminate cell organization. Mol Biol Cell (2017) 0.76

Application of the genome editing tool CRISPR/Cas9 in non-human primates. Dongwuxue Yanjiu (2016) 0.75

Organoid technologies meet genome engineering. EMBO Rep (2017) 0.75

RNA Interference in the Age of CRISPR: Will CRISPR Interfere with RNAi? Int J Mol Sci (2016) 0.75

Overcoming doxorubicin resistance of cancer cells by Cas9-mediated gene disruption. Sci Rep (2016) 0.75

Comprehensive Protocols for CRISPR/Cas9-based Gene Editing in Human Pluripotent Stem Cells. Curr Protoc Stem Cell Biol (2016) 0.75

Articles cited by this

Multiplex genome engineering using CRISPR/Cas systems. Science (2013) 55.53

RNA-guided human genome engineering via Cas9. Science (2013) 48.29

A TALE nuclease architecture for efficient genome editing. Nat Biotechnol (2010) 26.47

A Toll-like receptor recognizes bacterial DNA. Nature (2000) 26.34

One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell (2013) 24.00

Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat Biotechnol (2013) 21.32

DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol (2013) 19.99

CRISPR/Cas, the immune system of bacteria and archaea. Science (2010) 18.72

High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol (2013) 18.01

RNA-guided genetic silencing systems in bacteria and archaea. Nature (2012) 17.12

RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat Biotechnol (2013) 15.51

RNA-programmed genome editing in human cells. Elife (2013) 14.82

Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat Biotechnol (2013) 14.28

Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell (2013) 13.37

Chimeric nucleases stimulate gene targeting in human cells. Science (2003) 12.12

CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat Biotechnol (2013) 11.35

Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science (2012) 10.47

Targeted genome editing in human cells with zinc finger nucleases constructed via modular assembly. Genome Res (2009) 8.69

Genome engineering of Drosophila with the CRISPR RNA-guided Cas9 nuclease. Genetics (2013) 8.56

Enhancing gene targeting with designed zinc finger nucleases. Science (2003) 8.42

High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. Nat Biotechnol (2013) 8.40

Improving CRISPR-Cas nuclease specificity using truncated guide RNAs. Nat Biotechnol (2014) 6.85

An unbiased genome-wide analysis of zinc-finger nuclease specificity. Nat Biotechnol (2011) 6.44

Targeted chromosomal deletions in human cells using zinc finger nucleases. Genome Res (2009) 6.24

Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases. Genome Res (2013) 6.19

Heritable genome editing in C. elegans via a CRISPR-Cas9 system. Nat Methods (2013) 5.93

High-frequency genome editing using ssDNA oligonucleotides with zinc-finger nucleases. Nat Methods (2011) 5.68

Efficient TALEN-mediated gene knockout in livestock. Proc Natl Acad Sci U S A (2012) 4.99

Heritable gene targeting in the mouse and rat using a CRISPR-Cas system. Nat Biotechnol (2013) 4.58

Knockout mice created by TALEN-mediated gene targeting. Nat Biotechnol (2013) 4.31

Targeted genome modification of crop plants using a CRISPR-Cas system. Nat Biotechnol (2013) 4.19

A guide to genome engineering with programmable nucleases. Nat Rev Genet (2014) 4.15

CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activity. Nucleic Acids Res (2013) 4.11

Multiplex and homologous recombination-mediated genome editing in Arabidopsis and Nicotiana benthamiana using guide RNA and Cas9. Nat Biotechnol (2013) 3.84

Genome editing with modularly assembled zinc-finger nucleases. Nat Methods (2010) 3.79

Simultaneous generation and germline transmission of multiple gene mutations in rat using CRISPR-Cas systems. Nat Biotechnol (2013) 3.65

Engineering the Caenorhabditis elegans genome using Cas9-triggered homologous recombination. Nat Methods (2013) 3.59

Targeted mutagenesis in the model plant Nicotiana benthamiana using Cas9 RNA-guided endonuclease. Nat Biotechnol (2013) 3.20

Precision genome engineering with programmable DNA-nicking enzymes. Genome Res (2012) 3.05

A library of TAL effector nucleases spanning the human genome. Nat Biotechnol (2013) 2.87

Targeted chromosomal duplications and inversions in the human genome using zinc finger nucleases. Genome Res (2011) 2.85

Chromosomal translocations induced at specified loci in human stem cells. Proc Natl Acad Sci U S A (2009) 2.73

Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases. Bioinformatics (2014) 2.54

Preassembled zinc-finger arrays for rapid construction of ZFNs. Nat Methods (2011) 2.54

Heritable gene knockout in Caenorhabditis elegans by direct injection of Cas9-sgRNA ribonucleoproteins. Genetics (2013) 2.44

Highly efficient gene knockout in mice and zebrafish with RNA-guided endonucleases. Genome Res (2013) 2.28

Targeted gene knockout by direct delivery of zinc-finger nuclease proteins. Nat Methods (2012) 2.07

Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA. Genome Res (2014) 1.91

TALENs and ZFNs are associated with different mutation signatures. Nat Methods (2013) 1.66

Toll meets bacterial CpG-DNA. Immunity (2001) 1.58

Processing of DNA for nonhomologous end-joining by cell-free extract. EMBO J (2005) 1.38

Genotyping with CRISPR-Cas-derived RNA-guided endonucleases. Nat Commun (2014) 1.25

Cell-penetrating peptide-mediated delivery of TALEN proteins via bioconjugation for genome engineering. PLoS One (2014) 1.24

Engineering nucleases for gene targeting: safety and regulatory considerations. N Biotechnol (2013) 1.24

Site-directed nucleases: a paradigm shift in predictable, knowledge-based plant breeding. Trends Biotechnol (2013) 1.00